Resources

DIPLOSOL VS TYLENOL VS ALEVE

Gonzalez-Perez 2006: GI Bleeding occurs with paracetamol (Tylenol/acetaminophen)

Goldfine 2013: SESA lowers Hemoglobin A1c, lowers blood sugar, and lowers uric acid

Hauser 2016: SESA safety in cardiac patients

Kleinman 1988: Case report of salicylate toxicity due to unintentional overdose of SESA in a hemodialysis patient

Yang 2010: Plant origin of SESA (fissigtigma cavaleriei)

Wang 1988: Sick ethyroid due to SESA

Yang 2009 Betalactamase Inhibitor

Lanza 1989: Endoscopic findings of SESA vs Naprosyn (Aleve): SESA significantly better

DIPLOSOL Package Insert

Cryer 1990: Endoscopic findings of SESA’s ey as a placebo on mucosa of stomach./duodenum vs aspirin

Porro 1999: Endoscopic proof of greater safety on GI mucosa with SESA compared to the NSAID Piroxicam

Rosenkranz 1986: SESA’s active moiety salicylic acid has NO effect on renal prostaglandin production nor any effect on prostacyclin production

Hauser 2016 supplement: 30 months proof of cardiac safety of SESA in coronary artery patients

REFERENCES FOR FDA

O N RE J Int Med Res, 1979

Harrison 1992: No effect of food on absorption of SESA

Cohen 1979: SESA has no risk of GI blood loss compared to a placebo

One Case report of nephrotic syndrome due to SESA

Montrone SSA vs piroxicam 1989 DB with gastroscopy